However, when these mice were rechallenged with glioma cells i.c. on day 60 after the transplantation, the mice treated with αCD69 antibody lost their tumor-rejecting capacity (Fig. 7f, h) indicating that CD69 does not affect the executive function of TRM cells but is required for their prolonged residence and function in brains. This evidence concerns the gene CD69 and neoplasm.